Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine.
about
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseasesESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesSpontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and preventionQuantification of coronary microvascular resistance using angiographic images for volumetric blood flow measurement: in vivo validation.Impact of coronary vasa vasorum functional structure on coronary vessel wall perfusion distribution.Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha.Effect of metoprolol on myocardial apoptosis after coronary microembolization in ratsTNF-α-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigsCardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.Relationship between surface area of nonperfused myocardium and extravascular extraction of contrast agent following coronary microembolizationActivation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions.Central TNF inhibition results in attenuated neurohumoral excitation in heart failure: a role for superoxide and nitric oxide.NF-κB in the paraventricular nucleus modulates neurotransmitters and contributes to sympathoexcitation in heart failureProtection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient ratsChanges in left ventricular ejection fraction and coronary flow reserve after coronary microembolizationMyocardial hibernation: a delicate balance.Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway.TNFα protects cardiac mitochondria independently of its cell surface receptors.Endothelial NOS (NOS3) impairs myocardial function in developing sepsis.Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective StudySerum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Effect of metoprolol on myocardial apoptosis and caspase-9 activation after coronary microembolization in ratsRole of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury.Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization.N-Acetylcysteine effects on transforming growth factor-β and tumor necrosis factor-α serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction.The role of inflammatory cytokines in endothelial dysfunctionMaturation-induces endothelial dysfunction via vascular inflammation in diabetic miceTNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.Left ventricular remodeling with preserved function after coronary microembolization: the effect of methylprednisolone.Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Stents and statins: history, clinical outcomes and mechanisms.When are pro-inflammatory cytokines SAFE in heart failure?The potential role of sphingolipid-mediated cell signaling in the interaction between hyperglycemia, acute myocardial infarction and heart failure.Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development.Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning.Atorvastatin Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Swine After Coronary Microembolization.The PTEN/Akt Signaling Pathway Mediates Myocardial Apoptosis in Swine After Coronary Microembolization.
P2860
Q21296645-EAC76B3F-9412-43ED-849D-C65C77AB8BD5Q24289195-6830A2B1-220D-48C1-9DBB-F43E31ED0D35Q26828732-B6D422A4-5361-4C13-A606-7FA3CCFD3FD1Q30466911-29BEFEA9-55B0-401E-B212-190D8185B80AQ33427156-537C61CF-E688-4EC5-B5F9-8BEDC84AA165Q33912588-538938FB-E7B7-4333-AA35-7BCBBBE964B6Q34032217-35A0F3C0-6E81-48DF-B450-F1D5A91F8416Q34571516-139AF69A-3A9A-440F-9AB4-8B2A00C8AA71Q35048357-1047F3E1-BBC6-4D69-AB07-EF9F6AB65497Q35160059-35731B29-E51C-4992-9A29-7A012695E8C6Q35395763-5B997F0C-88FE-4E63-85AA-DA25C62350DFQ35584697-80B6FE62-BB69-4E95-9F98-8133B5D39433Q35680234-EFDB2A78-7381-40B9-AB86-13BAB3F0A0D6Q35707188-5F99E66B-ACE7-465C-8931-248FA7F3419BQ35737545-00EAE0DB-C16B-44BA-B988-8A342518E202Q35843944-E9BFA494-ACA7-4B96-A9A6-A03A78003CEFQ35962683-E405B2D2-AB00-4645-82D6-237E1EC1E08FQ36005489-BD755C53-4705-4103-B06A-E4CA6FD158BDQ36148170-CE3DB8BD-B075-4797-8EC9-F4A73FBA031AQ36683881-055D074A-C968-4930-9373-5F06E49A8C36Q36684243-961B4C71-8FE8-40B2-99E0-F44FEE47FDE4Q36814482-DCEF55A2-6249-4523-B359-C72F70CAAA84Q36923715-B3A97E40-6F39-4066-B2C9-901276A8FECCQ37004826-F8080954-9E89-4413-9F8E-0D5BA377C0CDQ37033164-313BD9DE-0AD2-414E-A521-0F2A9FAD8A01Q37038765-CAF725FD-7FC2-42B9-859A-CB2B1C1BEC33Q37187048-E9F2AB14-B216-4390-B177-9F5FD89DF2DCQ37199783-BF17999F-748B-4D3D-A680-943C1DD565AAQ37207043-7CCB4BAA-4E4F-486D-A29B-52957051CFCFQ37250713-F77B3DB6-BF75-43BF-AA47-4728CF164A24Q37406326-420F7F06-179C-47D7-BF45-3522FAE9A5A5Q37588844-67D64015-D88D-4D5F-88F5-6B53D996C8B6Q37744271-5D60EC02-5453-4BA4-8093-A6DBB0966D35Q37786646-124BE820-1BAB-42FF-92E0-D14730535C76Q37838085-0D27EC1F-1467-4A65-A6C8-6E99414A2AF7Q38023943-CC305227-AEBB-4EF7-ACB2-C6EC91577E3BQ38112347-B3733D02-E020-4CAB-AB6D-6B618A8B4133Q38125624-5219A68E-4A24-4108-80D7-D09F42A7AB93Q39429885-93F80969-E91C-4522-88B0-94A6620052EFQ40023359-31001222-4CDC-43CF-9153-20F4349C574D
P2860
Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Myocardial dysfunction with co ...... factor-alpha, and sphingosine.
@en
Myocardial dysfunction with co ...... factor-alpha, and sphingosine.
@nl
type
label
Myocardial dysfunction with co ...... factor-alpha, and sphingosine.
@en
Myocardial dysfunction with co ...... factor-alpha, and sphingosine.
@nl
prefLabel
Myocardial dysfunction with co ...... factor-alpha, and sphingosine.
@en
Myocardial dysfunction with co ...... factor-alpha, and sphingosine.
@nl
P2093
P1433
P1476
Myocardial dysfunction with co ...... factor-alpha, and sphingosine.
@en
P2093
Anita van De Sand
Arne Krüger
Astrid Büchert
Claus Martin
Gerd Heusch
Hilmar Dörge
Ina Konietzka
Matthias Thielmann
Sergej Belosjorow
Uwe Schwanke
P304
P356
10.1161/01.RES.0000014451.75415.36
P577
2002-04-01T00:00:00Z